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Abstract 
 
Haemophilia is a potentially disabling condition associated with high financial costs 
and so the need for robust measures to evaluate outcome of care is essential. This 
paper is a review of some of the outcome measures commonly used to evaluate 
treatment in haemophilia and includes quality of life measures, evaluation of the 
musculoskeletal system and orthopaedic surgical procedures. Quality of life 
questionnaires are discussed with particular reference to the SF36 and AIMS2. 
Results of published studies to date demonstrate variable results. Overall having 
haemophilia appears to reduce quality of life compared to normal population 
figures. Several factors are perceived to reduce quality of life and these include 
being HIV positive, having impairments and a history of orthopaedic surgery. The 
evaluation of the musculoskeletal system is important in order to detect any 
deterioration over time. Various standardised measurement tools are outlined. 
Orthopaedic surgical procedures have also been evaluated in patients with 
haemophilia. To date the Hospital for Special Surgery Knee rating scale has been 
most commonly used to evaluate the outcome of total knee replacement. The 
limitations of this system for patients with haemophilia are outlined. Overall these 
measures provide useful tools to evaluate outcome but none have been developed 
specifically for patients with haemophilia. Further studies would be useful to 
evaluate these tools and others in more depth.  
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Assessing the outcome of treatment is an essential component of evaluation of 
practice. Haemophilia is a potentially disabling condition associated with very high 
financial costs and so the need for the evaluation of interventions is especially 
important. This paper will review commonly used measures in the evaluation of 
outcome in haemophilia. These include health related quality of life (QoL) 
questionnaires and outcome measures to evaluate impairments and orthopaedic 
surgical procedures commonly used for haemophilic patients. Finally, some 
recommendations for future research will be discussed. 
 
Musculoskeletal dysfunction is a common manifestation of haemophilia particularly 
in the severely affected patient. Repeated bleeding into joints, commonly knees, 
elbows and ankles can lead to arthropathy with associated pain, loss of range of 
movement and loss of function [1]. Medical management focuses on prompt and 
adequate treatment with factor replacement to minimise the effects of bleeding and 
prophylactic regimens are recommended for severely affected patients [2] [3] [4]. 
Over the last twenty years the usage of factor replacement has risen exponentially 
predominately as a result of the increased use of prophylaxis [5]. Factor 
replacement is a very expensive commodity. In 1994 the cost of factor replacement 
alone in the United Kingdom was in the region of £50 million [6] accounting for 50-
85% of the total expenditure of haemophilia care [5]. Purchasers need to be 
satisfied that these high cost resources are beneficial in improving health. Despite 
the availability of factor replacement, patients still present with musculoskeletal 
bleeds and their sequelae and older patients who did not have the benefit of 
adequate factor replacement in their childhood may develop joint arthropathy. This 
requires monitoring over time and specific treatment, including physiotherapy or 
surgery, may be required if conservative treatment fails.  
 
Recent Government reports have highlighted the need to use robust measures to 
assess the outcome of care for all patients [7]. The Haemophilia Chartered 
Physiotherapists Association (HCPA) Standards for Haemophilia [8] identified that 
each physiotherapy session should be evaluated using appropriate assessment 
tools. In the recently revised Chartered Society of Physiotherapy Core Standards of 
Physiotherapy Practice [9], standard 6 states ‘Taking account of the patient’s 
problems, a published, standardised, valid, reliable, and responsive outcome 
measure is used to evaluate the change in the patient’s health status’. There are a 
number of instruments that can be used to evaluate outcome including impairment 
measures, pain scales, functional scales, activity levels and QoL measures. In view 
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of the considerable costs associated with haemophilia management, the need to 
evaluate the impact of various factor replacement regimens [10], [11] and any 
changes in health status following physiotherapy and other interventions is 
paramount. 
 
Evaluation of Quality of Life (QoL) 
Health related QoL is a broad term that covers a number of different concepts 
including physical status, role, social integration, psychological status and 
perceptions of health [12]. Quality of life instruments need to include these different 
domains in their questionnaires. There is debate in the literature regarding whether 
the measurement of each domain or an overall score is more important in 
evaluating different interventions [13], [14]. According to Fuhrer [15] many studies 
carried out on people with physical disabilities in the United States of America 
(U.S.A.) have reported lower levels of QoL compared to the normal population. 
Other authors however, have identified that a good QoL is often reported in 
patients with marked disabilities [16], [17]. This suggests that QoL is a complex 
phenomena and the need for multiple methods of evaluation are required.  
 
Standardised questionnaires have been used to evaluate QoL in patients with 
haemophilia. The Medical Outcomes Study Short Form 36 (SF36) is a generic 
measure of QoL that is self-administered. It consists of eight domains, physical 
functioning, role limitations due to physical problems and role limitations due to 
mental problems, bodily pain, social function, mental health, vitality and general 
health perceptions providing an overall score for physical and mental domains [18]. 
The Arthritis Impact Measurement Scale 2 (AIMS2) is a revised and expanded 
version of the original AIMS self administered questionnaire designed to assess 
health status in patients with arthritic conditions. It includes physical, social and 
emotional dimensions in twelve categories and also includes sections on the 
impact of arthritis, levels of satisfaction, areas for health improvement and 
perceived future health needs [19].  Both questionnaires focus on health status in 
the previous four weeks prior to their administration. 
 
Roosendaal et al. [20] were among the first to evaluate QoL in their cohort of 
patients with haemophilia. A self-administered questionnaire was sent to all their 
Dutch patients with haemophilia requesting information on employment, education, 
and joint impairment and a response rate of 81% (947 forms) was achieved. 
Results were compared to normal population data. The patient group was less 
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likely to be married or have children and 41% had joint damage. Quality of life was 
assessed as a subjective measure as good or excellent in 80% which was no 
different to the population as a whole [20]. A study by Albrecht and Devlieger [17] 
also reported that in interviews with 153 people who had developed a range of 
disabilities over 50% reported a good or excellent QoL. This situation when people 
with apparent less optimal health report that they have good QoL has been labelled 
‘the disability paradox’. This appeared to relate to the subjects being in control of 
their life, being able to support others and having religious faith which provided a 
purpose in life. Other interviewees reported that a re-evaluation of priorities after 
the onset of their ill health and the ability to cope well with their disability which 
gave a sense of achievement were also important factors in how they viewed their 
QoL [17]. It was interesting to note that these changes in perception often occurred 
some time after the onset of the illness rather than immediately. 
 
Although Roosendaal et al. [20] reported that patients with haemophilia had a QoL 
equal to the general population, other studies investigating QoL have identified that 
patients with haemophilia were more likely to have poorer QoL [11] [21], [22]. 
Miners et al. [11] evaluated QoL using the SF 36 in 168 patients with varying 
degrees of severity of haemophilia and identified that severely affected patients 
were more likely to have poorer QoL. Aznar et al. [21] evaluated the orthopaedic 
status of 70 severely affected patients with haemophilia with a median age of 22 
years and administered the SF 36. Significant differences were identified for all 
dimensions of the SF 36 except role-emotional and mental health suggesting that 
QoL was poorer for the haemophilic group than for a similarly age matched group 
of normal males. Mohlo et al. [22] also used the SF 36 in a large multi-centre 
haemophilia study in France and identified that the domains, ‘pain’, ‘general health’ 
and ‘vitality’ scored poorly suggesting that those aspects of QoL were most 
affected.  
 
Several factors have been perceived to reduce QoL in patients with haemophilia. 
These include being HIV positive, having impairments due to arthropathy or 
repeated bleeds and also a history of orthopaedic surgery.  
 
Djulbegovic et al. [23] used two outcome measures to evaluate QoL, the SF 36 and 
the quality of well being scale (QWB) to determine the impact of being HIV positive 
on QoL in a group of eight haemophilic patients who were HIV positive and eleven 
who were HIV negative. The SF 36 demonstrated lower scores for ‘health 
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perception’ and ‘pain domains’ suggesting poorer QoL in patients who were HIV 
positive. The QWB scale assesses mobility, physical activity and social activity to 
provide an overall score of health status [24] and resulted in a lower score for the 
HIV positive patients [23]. Tanaka et al. [25] used the AIMS2 and a satisfaction with 
daily life (SDL) questionnaire to evaluate QoL in 21 asymptomatic HIV positive and 
17 HIV negative patients. The AIMS2 demonstrated that the HIV positive patients 
were significantly more dissatisfied with social activities and had lower mood. The 
SDL questionnaire identified more differences than the AIMS2 and was therefore 
considered to be more responsive. There were no significant differences between 
the groups in overall satisfaction or health perception [25]. There were also no 
differences in clinical severity of arthropathy between groups, however this was 
only determined by X-ray changes that may not be a sensitive measure of clinical 
symptoms [26]. The authors suggested that the differences were therefore due to 
the effects of being HIV positive [25].  
 
Other studies have not identified a correlation between being HIV positive and 
lower QoL scores [11], [22]. These conflicting results may suggest that the method 
of evaluation may not be sensitive enough to detect differences or that being HIV 
positive does not necessarily further reduce QoL. It has been suggested that 
people with disabilities are able to maintain or re-establish a balance and adapt to a 
new health problem [17]. Other issues which may confound the evaluation of QoL 
are the occurrence of what has been termed ‘beta change’ or ‘gamma change’ [16] 
Beta change can occur if there is a change of perceptions due to previous 
experiences. Gamma change relates to a change in a patient’s priorities following 
an illness or life event so that different degrees of importance are attached to the 
various domains [16]. Other mechanisms such as coping strategies, expectations 
and optimism can also influence QoL results [16] Some of these mechanisms were 
highlighted in the study by Albrecht and Devlieger [17] and need to be considered 
when evaluating outcome in patients with haemophilia. 
 
The relationship between joint impairment and QoL has also been investigated 
[21], [22], [27]. The cross sectional study by Aznar et al. [21] included 
administration of the SF 36 and a clinical evaluation of knees, ankles and elbow 
joints based on the World Federation of Haemophilia (WFH) joint scoring system 
[28]. Joint measurements suggesting impairments were found to have a positive 
correlation with ‘role physical’ and ‘vitality’ dimensions of the SF 36. Mohlo et al. 
[22] identified that younger patients appeared to have a better QoL and this was 
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hypothesised to be due to reduced joint dysfunction that was associated with more 
effective factor replacement regimens [22]. Solovieva [27] also used the SF 36 and 
a questionnaire to determine the clinical manifestations of arthropathy in 150 
patients with haemophilia. An increase in morbidity correlated with the domains, 
‘physical role’, ‘bodily pain’, ‘vitality’ and ‘social functioning’ in the SF 36 suggesting 
that those patients with more disability had poor scores in those domains. Overall, 
these results suggest that greater joint impairments are associated with poorer 
QoL. 
 
Other factors considered to influence QoL are bleeding frequency or history of 
orthopaedic surgery. Miners et al. [11] identified that these variables did not 
correlate with QoL scores and suggested that the SF 36 may not be sensitive 
enough for patients with haemophilia. However, Mohlo et al. [22] identified that 
those patients who required orthopaedic treatment or who had more joint bleeds 
had poorer QoL scores.  
 
The SF 12, a shortened version of the SF 36 has been used as part of a battery of 
assessment tools to evaluate QoL in patients with haemophilia undergoing total 
knee replacements [29]. The results demonstrated improvements in scores post 
operatively but the results were still lower than normal values suggesting that other 
joint impairments were influencing the scores. Unfortunately both pre and post-
operative evaluations were only performed after the surgery and this may have 
influenced how the patients perceived their pre operative health [29].  
 
Only one study has reported on the use of a QoL outcome measure to evaluate 
physiotherapy [30]. The original AIMS questionnaire was used to evaluate the 
effectiveness of an individualised physiotherapy programme for an unspecified 
number of patients with haemophilia. Few details were provided but the results 
indicated an improvement in impairment measures and significant improvements in 
AIMS scores following physiotherapy. The results helped to ensure that the 
physiotherapy service became permanent and was funded by the purchasers [30].  
 
Overall the results of the published studies demonstrated a lower QoL in patients 
with haemophilia compared to normal population figures (see Table 1). The effect 
of being HIV positive as well as having haemophilia demonstrated conflicting 
results on QoL. The two studies that used the SF 36 demonstrated that being HIV 
positive had no apparent effect on QoL whereas other measures identified even 
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lower QoL scores in this group. This may suggest that the SF 36 is not sensitive 
enough to detect any changes in health status. It has been reported in a review of 
QoL measures suitable for HIV positive patients that the SF 36 does not assess 
‘cognitive distress’ and that other assessment tools are required to assess this 
domain [24].  
 
Joint impairments were correlated with reduced QoL. This is not unexpected in 
view of the marked physical health problems that these patients still experience. 
Albrecht and Devlieger [17] identified that factors associated with poor ratings of 
health included the occurrence of pain and fatigue, components that are very 
pertinent for patients with haemophilic arthropathy. Overall, the results would 
suggest that more effective prophylactic regimens which aim to reduce impairments 
do improve QoL. However, the variability of factor replacement regimens within the 
patient cohorts and the cross sectional nature of the reported studies make it 
difficult to exclude other variables.  
 
The SF 36 has not been specifically validated in patients with haemophilia but its 
value has been demonstrated in patients with arthritic conditions [21]. However 
patients with haemophilia have a different pattern of arthritis that may not be 
comparable to other arthritic conditions. The SF 36 has also been reported to 
demonstrate ‘floor’ effects in patients on renal dialysis [31] suggesting that it may 
not be responsive enough to detect changes in health status in some conditions 
[12]. ‘Ceiling effects’ have also been reported, particularly in functional domains 
[32] although again these effects have not been specifically investigated in patients 
with haemophilia and therefore require further investigation.  
 
The validity and reliability of the Dutch version of the AIMS2 have been reported as 
satisfactory in a haemophilic group [33]. The domains ‘social interaction’ and 
‘symptoms’ scored highest in their study suggesting more marked problems in 
those areas. Sections of the AIMS2 on hand and finger function are less relevant in 
patients with haemophilia as hand bleeds are rarely reported [1]. Van Meeteren et 
al. [33] suggested that this item should be redesigned. It has also been suggested 
that the use of a generic outcome measure, such as the SF 36 and a disease 
specific measure, such as the AIMS2 may be more valuable than using one tool in 
isolation to assess QoL [18].  
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Evaluation of Physical Status 
The musculoskeletal system of a patient with haemophilia needs to be monitored 
on a long term basis as there may be a gradual loss of range of movement over 
time in the knees, ankles and elbows and other joints in the presence of 
arthropathy [34]. Ideally an annual review is undertaken to evaluate the 
musculoskeletal system and to determine any deterioration in joint range or muscle 
strength so that appropriate intervention such as physiotherapy can be undertaken 
if necessary. A standardised assessment form may assist in the collection of data 
[8]. The classification developed by the Orthopaedic Advisory Committee of the 
World Federation of Haemophilia can also be used to assess musculoskeletal 
function [28]. However it was designed at a time when factor replacement was less 
available and consequently more severe arthropathy tended to result. It may not be 
sensitive enough to detect the more minor changes which may be apparent in 
children and young adults at the present time [35]. Preliminary investigation has 
suggested that a revised version of the WFH scale, the Colorado Physical 
examination instrument and a newly developed Child Physical Examination 
instrument may be more appropriate in evaluating musculoskeletal function in 
younger patients with haemophilia [35]. 
 
Evaluation of Orthopaedic Surgery 
Orthopaedic surgery may be performed for patients with haemophilia to manage 
severe arthropathy when conservative methods have failed. The use of total joint 
replacements can be beneficial in relieving the symptoms of chronic arthropathy 
but it is also important to identify and use robust measures to evaluate the 
procedures. The Hospital for Special Surgery (HSS) knee rating scale has been 
most commonly used to evaluate changes following total knee replacement in 
patients with haemophilia. This scale includes assessment of pain, function, range 
of movement, strength and stability [36]. Each parameter is weighted to give a 
maximum score out of 100, where 85-100 is rated as excellent, 70-84 is good, 60-
69 is fair and under 60 is classified as unsatisfactory [37]. Studies using the HSS 
scale generally report good or excellent scores post surgery in patients with 
haemophilia (for a review of studies see Beeton et al [38]). However it is 
recognised that patients who have many joints affected may not demonstrate such 
good improvements in scores post operatively as patients with an isolated knee 
problem [37]. This may be an issue for patients with haemophilia. Pain is almost 
always improved following surgery however the overall range of movement may not 
change although the flexion deformity may improve [38]. Therefore these patients 
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may score less well on the rating scale even though they may have improved 
function and be painfree. For this reason other methods of evaluating outcome may 
also need to be considered.  
 
Total hip replacements are less commonly undertaken for patients with 
haemophilia and standardised measures of evaluation not so widely used. In a 
recent review of total hip replacements in haemophilic patients only one study had 
used a standardised rating scale [38]. Increased use of standardised measures 
may be valuable in providing more robust evaluation of the benefits of surgery of 
this kind. 
 
Conclusion 
Further investigation into the methods of evaluation of outcome of care in patients 
with haemophilia needs to be undertaken. Currently standardised QoL measures, 
impairment measures and rating scales for surgical procedures are used. Further 
studies would be useful to explore these tools and other instruments in more depth 
in order to identify the most appropriate methods of evaluating the outcome of 
various interventions. Ultimately specific measures which are valid, reliable and 
responsive to changes in the health status of patients with haemophilia may need 
to be developed.  
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Table 1 
 
Summary of Results of Quality of Life Studies 
 
Quality of life 
evaluation 
Results Measurement 
tool 
Author 
Overall QoL rating Equal to normal 
population 
Subjective rating Roosendaal et al 
1990 
 Lower than normal 
population 
SF 36 Miners et al 1999 
 Lower than normal 
population 
SF 36 Aznar er al 2000 
 Lower than normal 
population 
SF 36 Mohlo et al 2000 
Effect of being HIV 
positive on QoL 
No difference SF 36 Miners et al 1999 
 No difference SF 36 Mohlo et al 2000 
 Lower QoL scores 
in ‘health 
perception’ and 
‘pain’ 
SF 36 Djulbegovic et al 
1996 
 Lower QoL score QWB Djulbegovic et al 
1996 
 Lower QoL scores 
in ‘social activities’ 
and ‘mood’ 
AIMS Tanaka et al 1999 
 Lower QoL scores SDL Tanaka et al 1999 
Effect of joint 
impairment on 
QoL 
Correlated with 
‘role physical’ and 
‘vitality’ 
SF 36 Aznar et al 2000 
 Correlated with 
‘role physical’ 
‘bodily pain’, 
‘vitality’ and ‘social 
functioning’ 
SF 36 Solovieva 2001 
Effect of bleeding 
frequency on QOL 
No correlation  SF 36 Miners et al 1999 
 Positive correlation 
with ‘physical 
function’, ‘pain’, 
‘restrictions due to 
physical problems’ 
and ‘emotional 
problems’ 
SF36 Mohlo et al 2000 
Effect of total knee 
replacement on 
QoL 
Improved scores, 
still lower than 
normal population 
SF 12 Schick et al 1999 
Effect of 
physiotherapy on 
QoL 
Improved scores AIMS Cornwall 2000 
 
QWB = quality of well being scale 
SDL  = satisfaction with daily life 
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